Cargando…

An unexpected N-terminal loop in PD-1 dominates binding by nivolumab

Cancer immunotherapy by targeting of immune checkpoint molecules has been a research ‘hot-spot' in recent years. Nivolumab, a human monoclonal antibody targeting PD-1, has been widely used clinically since 2014. However, the binding mechanism of nivolumab to PD-1 has not yet been shown, despite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Shuguang, Zhang, Hao, Chai, Yan, Song, Hao, Tong, Zhou, Wang, Qihui, Qi, Jianxun, Wong, Gary, Zhu, Xiaodong, Liu, William J., Gao, Shan, Wang, Zhongfu, Shi, Yi, Yang, Fuquan, Gao, George F., Yan, Jinghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303876/ https://www.ncbi.nlm.nih.gov/pubmed/28165004 http://dx.doi.org/10.1038/ncomms14369

Ejemplares similares

The FG Loop of PD-1 Serves as a “Hotspot” for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy
por: Chen, Danqing, et al.
Publicado: (2019)

Glycosylation-independent binding of monoclonal antibody toripalimab to FG loop of PD-1 for tumor immune checkpoint therapy
por: Liu, Hongchuan, et al.
Publicado: (2019)

The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
por: Shi, Rui, et al.
Publicado: (2020)

Investigating the Role of the N-Terminal Loop of PD-1 in Binding Process Between PD-1 and Nivolumab via Molecular Dynamics Simulation
por: Liu, Wenping, et al.
Publicado: (2020)

Crystal clear: visualizing the intervention mechanism of the PD-1/PD-L1 interaction by two cancer therapeutic monoclonal antibodies
por: Tan, Shuguang, et al.
Publicado: (2016)

Molecular basis of EphA2 recognition by gHgL from gammaherpesviruses
por: Su, Chao, et al.
Publicado: (2020)

Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab
por: Tan, Shuguang, et al.
Publicado: (2017)

Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex
por: Wang, Qihui, et al.
Publicado: (2019)

Pembrolizumab Induces an Unexpected Conformational Change in the CC′-loop of PD-1
por: Roither, Bernhard, et al.
Publicado: (2020)

Structure of the S1 subunit C-terminal domain from bat-derived coronavirus HKU5 spike protein
por: Han, Xue, et al.
Publicado: (2017)

Identification of a hotspot on PD-L1 for pH-dependent binding by monoclonal antibodies for tumor therapy
por: Liu, Hongchuan, et al.
Publicado: (2020)

Remarkably similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies
por: He, Mengnan, et al.
Publicado: (2017)

Molecular Basis of Binding between Middle East Respiratory Syndrome Coronavirus and CD26 from Seven Bat Species
por: Yuan, Yuan, et al.
Publicado: (2020)

MERS-CoV spike protein: Targets for vaccines and therapeutics
por: Wang, Qihui, et al.
Publicado: (2016)

Initial experience of anti-PD1 therapy with nivolumab in advanced hepatocellular carcinoma
por: Feng, Duan, et al.
Publicado: (2017)

Publisher Correction: A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
por: Huang, Qingrui, et al.
Publicado: (2021)

A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
por: Huang, Qingrui, et al.
Publicado: (2021)

Putative Receptor Binding Domain of Bat-Derived Coronavirus HKU9 Spike Protein: Evolution of Betacoronavirus Receptor Binding Motifs
por: Huang, Canping, et al.
Publicado: (2016)

Transition of the PD-1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re-challenge
por: Nose, Taku, et al.
Publicado: (2022)

Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry
por: Sun, Huan, et al.
Publicado: (2020)

Unexpected Response to Nivolumab in a “Fast Progressor” Head and Neck Cancer Patient
por: Napolitano, Martina, et al.
Publicado: (2019)

Nivolumab (PD-1 Inhibitor) Induced Exacerbation of Psoriasis
por: George, Anju, et al.
Publicado: (2020)

An unexpected catalyst dominates formation and radiative forcing of regional haze
por: Zhang, Fang, et al.
Publicado: (2020)

Isolation of Monoclonal Antibodies from Zika Virus-Infected Patient Samples
por: Wang, Qihui, et al.
Publicado: (2020)

Structural insights into the cis and trans assembly of human trophoblast cell surface antigen 2
por: Sun, Meng, et al.
Publicado: (2021)

Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
por: Paoluzzi, L., et al.
Publicado: (2016)

Contribution of intertwined loop to membrane association revealed by Zika virus full‐length NS1 structure
por: Xu, Xiaoying, et al.
Publicado: (2016)

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
por: Lu, Guangwen, et al.
Publicado: (2013)

Molecular dynamics of the immune checkpoint programmed cell death protein I, PD-1: conformational changes of the BC-loop upon binding of the ligand PD-L1 and the monoclonal antibody nivolumab
por: Roither, Bernhard, et al.
Publicado: (2020)

A neutralizing-protective supersite of human monoclonal antibodies for yellow fever virus
por: Li, Yan, et al.
Publicado: (2022)

IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer
por: Ding, Guoping, et al.
Publicado: (2019)

Soluble PD-L1 as an early marker of progressive disease on nivolumab
por: Mahoney, Kathleen M, et al.
Publicado: (2022)

Troubleshooting for Ureteroscopy Complicated by Unexpected Guidewire Looping and Entrapment
por: Efthimiou, Ioannis, et al.
Publicado: (2017)

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
por: Yuan, Yuan, et al.
Publicado: (2017)

GI-type T4SS-mediated horizontal transfer of the 89K pathogenicity island in epidemic Streptococcus suis serotype 2
por: Li, Ming, et al.
Publicado: (2011)

An unexpected role for p53 in regulating cancer cell–intrinsic PD-1 by acetylation
por: Cao, Zhijie, et al.
Publicado: (2021)

Characterization of the high-affinity anti-CTLA-4 monoclonal antibody JS007 for immune checkpoint therapy of cancer
por: Guan, Jiawei, et al.
Publicado: (2022)

The terminal loop region controls microRNA processing by Drosha and Dicer
por: Zhang, Xiaoxiao, et al.
Publicado: (2010)

Cross-species recognition of SARS-CoV-2 to bat ACE2
por: Liu, Kefang, et al.
Publicado: (2021)

Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor
por: Guo, Liting, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p6s9v7t8f8tbg0n5h0ip0h5ri1